All News

acr_session2.jpeg

EULAR 2021 - Opening Day

d Jack Cush, MD

RheumNow has begun covering EULAR 2021, the premier Rheumatology Congress that is usually held in Europe, but has gone virtual in 2021 because of the pandemic. We have several faculty members around the world reporting on the this year's meeting.

Please visit RheumNow.com daily for the latest videos, tweet summaries, news articles and podcasts emanating from EULAR.

Look for our coverage on these and other important topics:

Read Article
EULAR19.abstract.jpg (keep)

Featured Abstracts from Industry at EULAR 2021

d Jack Cush, MD

Many great presentations this week at EULAR 2021 will feature industry sponsored clinical trials and reports.  Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.

Read Article
Feet, foot

Foot Pain Commonly Overlooked in RA

d MedPage Today

Foot pain is a common but underappreciated symptom of rheumatoid arthritis (RA) and can be associated with worse disease, European researchers found.

Read Article
gout podagra inflammed

Best Interventions for Gout Flares

d Jack Cush, MD

A recent metanalysis assessed the comparative efficacy of current first-line pharmacologic antiinflammatory interventions for gout flares and surmised that canakinumab and intravenous or intramuscular corticosteroids are superior to  nonsteroidal antiinflammatory drugs [NSAIDs].

Read Article
"We can be soloist or collaborators." - Mark Pollock, keynote speaker #EULAR2021, inspires people to build resilience and collaborate w/others to achieve more than they thought possible. He was the 1st blind person to race to the South Pole @RheumNow https://t.co/qYpBr1I9US

Links:

k dao KDAO2011 ( View Tweet)

New download available! Difficult RA Defined https://t.co/6WGMEiwiUk https://t.co/VTCm4cuyRe

Links:

Dr. John Cush RheumNow ( View Tweet)
Novartis announced that Cosentyx (secukinumab) has received FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis #EULAR2021 https://t.co/JlkmjLwqQ8

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Gout doesnt get to the hands until its done its damage below (MTP, ankle, knee) and usually only in those with severe tophaceous goutdCan also present as dactylitis or Carpal tunnel. Women on diuretics w/ CKD can get gout in Nodal OA joints https://t.co/EpBpdC31J6
Dr. John Cush RheumNow ( View Tweet)
Hands-Down Rheumatology - Whats your diagnosis - Erosive Hand OA or Psoriati https://t.co/abYqBNhFyX arthritis?

Links:

Dr. John Cush RheumNow ( View Tweet)

Starting Thursday we'll be covering EULAR. Tune in for coverage on KOL perspective highlights, clinical trial highlights and much more. https://t.co/L7ryiQ5HdV
Dr. John Cush RheumNow ( View Tweet)
RNL 2021 - ACR COVID Vaccine Guidance: Dr. Jeff Curtis https://t.co/nJgbwB1RdA https://t.co/0Jir2vtaFH

Links:

Dr. John Cush RheumNow ( View Tweet)
Hands-Down Rheumatology - Sarcoidosis usually presents as a monarthritis or oligoarthritis. Late sarcoid arthritis affects knees, ankles, fingers (dactylitis). Bony lesions show honeycomb trabecular pattern). https://t.co/lmXBbJz6ts

Links:

Dr. John Cush RheumNow ( View Tweet)

Top May Tweet: Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Mechanics hands - rough, thickened/caloused, cracks/fissures; seen in 20-70% of dermatomyositis; associated with the anti-synthetase syndrome, but also w/ lung dz and amyopathic DM https://t.co/bkCI3SUXNh https://t.co/jrOGkKAm9z

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Swollen Hands In Rheumatoid Arthritis - could be from synovitis, tenosynovitis, edema, effusion, bony hypertrophy, nodules, secondary OA. https://t.co/dRCMzgdHqf

Links:

Dr. John Cush RheumNow ( View Tweet)

Hands-Down Rheumatology - Erosive hand osteoarthritis (EHOA) affects 2.6% of knee OA pts (from Osteoarthritis Initiative) Risk factors - older [RR 0.76), female (RR=1.73), greater OA severity, and "thinner bones" https://t.co/3s8E4F6QDR

Links:

Dr. John Cush RheumNow ( View Tweet)

News: Triple DMARD Therapy Bested by Biologics in Swedish Registry The Swedish Register compared outcomes of 1502 RA patients initiating either biologics plus MTX or triple therapy and showed similar rates of sustained remission. https://t.co/7JJxGF1tHz https://t.co/ht6kAsJkb9

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Heart, Lung & Liver (5.28.2021) Dr Jack Cush reviews the news and journal reports from this past week on RheumNow. https://t.co/a9fvgaJVnQ https://t.co/r3nbf2Ftdb

Links:

Dr. John Cush RheumNow ( View Tweet)
News: EULAR Guidelines on Intraarticular Therapy EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force. https://t.co/Z6vC0x9zY1 https://t.co/gVCWMIJxtu

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of National inpatient sample database (2015 to 2017) showed the frequency of atrial fibrillation in rheumatic disease (RD) pts finding that AF frequency highest in gout followed by vasculitis, and PMR. RD Mortality was 2 fold higher with AF. https://t.co/enno6hrKOI

Links:

Dr. John Cush RheumNow ( View Tweet)

×